Abstract
The in vitro activity of A-56268 (TE-031) was determined by either standard agar dilution or macrobroth tube dilution and comapred with erythromycin and other antimicrobial agents against 329 clinical aerobic and anaerobic bacterial isolates. A-56268 showed good to excellent in vitro activity against methicillin-sensitiveStaphylococcus aureus,Neisseria meningitidis, and most anaerobes tested with the exception ofBacteroides fragilis isolates. A-56268 had relatively poor activity against coagulase-negative staphylococci and methicillin-resistantStaphylococcus aureus. Except forHaemo philus spp., the activity of A-56268 was similar to or more potent than erythromycin against all other isolates tested. A-56268 did not have significant bactericidal activity against any of the isolates examined.
Similar content being viewed by others
References
Peaxson, R. D., Steigbigel, R. T., Davis, H. T., Chapman, S. W.: Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrobial Agents and Chemotherapy 1980, 18: 699–708.
Washington, J. A., II, Sutter, V. L.: Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lennette, E. H., Balows, A., Hausier, W. J., Traunt, J. P. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, D. C. 1980, p. 453–458.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodinka, R.L., Jack-Wait, K. & Gilligan, P.H. Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur. J, Clin. Microbiol. 6, 103–108 (1987). https://doi.org/10.1007/BF02097212
Issue Date:
DOI: https://doi.org/10.1007/BF02097212